CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

CVS Caremark, Express Scripts and OptumRx and have fended off federal legislation targeting pharmacy benefit managers, but ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare ...

Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid ...

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

Cigna Group on Friday reported a $1.3 billion profit for the first quarter of 2025, a sharp turnaround from a year-earlier ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Investors will be looking to see whether the company goes the way of UnitedHealth Group on the one hand, or CVS Health on the ...

(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists ...

This bankruptcy is more final than the one Rite Aid filed in 2023. Rather than just a financial reorganization, the company is putting its remaining 1,200-plus brick-and-mortar locations — down from ...